Results 61 to 70 of about 1,503,193 (305)

Sleep bruxism, painful temporomandibular disorders, and self reported headache in a sample population of adolescents [PDF]

open access: yes, 2012
Fernandes G, Franco AL, Bonafé F, Gonçalves D, Camparis C. Sleep bruxism, painful temporomandibular disorders, and self reported headache in a sample population of adolescents. Headache Medicine.
Gonçalves, Daniela   +4 more
core   +1 more source

Discordance Between Systemic Lupus Erythematosus Disease Activity Index Domain Weights and Their Association With Organ Damage Accrual

open access: yesArthritis Care &Research, EarlyView.
Objective Studies of damage accrual in patients with systemic lupus erythematosus (SLE) show associations with disease activity measured by the SLE Disease Activity Index 2000 (SLEDAI‐2K), but these associations are imperfect. SLEDAI scores are powerfully influenced by weightings (1–8) assigned to each domain.
Kevin Zhang   +8 more
wiley   +1 more source

Headache and Psychiatric Disorders

open access: yesPediatric Neurology Briefs, 1998
Headaches and psychopathology were evaluated in 1013 children, aged 9 to 15 years, enrolled in the Great Smoky Mountains Study, and reported from Duke University Medical Center, Durham, NC.
J Gordon Millichap
doaj   +1 more source

Mechanisms of increased sensitivity to noise and light in migraine headache [PDF]

open access: yes, 1993
To determine whether phonophobia is a manifestation of loudness recruitment, the hearing and auditory discomfort thresholds to an 8000 Hz tone were measured during the headache-free interval and again during an attack of migraine in 16 migraine sufferers.
Woodhouse, A., Drummond, P.D.
core  

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

open access: yesArthritis Care &Research, EarlyView.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci   +25 more
wiley   +1 more source

Debate: Are cluster headache and migraine distinct headache disorders?

open access: yesThe Journal of Headache and Pain, 2022
Cluster headache and migraine are regarded as distinct primary headaches. While cluster headache and migraine differ in multiple aspects such as gender-related and headache specific features (e.g., attack duration and frequency), both show clinical ...
Mohammad Al-Mahdi Al-Karagholi   +5 more
doaj   +1 more source

Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers [PDF]

open access: yes, 2006
Sensitivity to light was investigated 5 and 8 h after consumption of an amino acid drink which contained L-tryptophan (balanced amino acid condition: 19 controls and 22 migraine sufferers) or which produced a short-term reduction in brain serotonin ...
Drummond, P.D.
core  

A CPH-Like Picture in Two Patients with an Orbitocavernous Sinus Syndrome [PDF]

open access: yes, 1997
Two patients with retroorbital pain syndromes with or without paresis of cranial nerves developed weeks after ipsilateral headache resembling chronic paroxysmal hemicrania (CPH) but without autonomic features.
Straube, A.   +2 more
core   +1 more source

Validation of Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric Measures for Children With Chronic Nonbacterial Osteomyelitis

open access: yesArthritis Care &Research, EarlyView.
Objective To assess the validity of the Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric measures in patients with chronic nonbacterial osteomyelitis (CNO). Methods Within the longitudinal patient registry of CNO, English‐speaking patients aged 8 years and older self‐reported PROMIS Pediatric measures of fatigue, pain ...
Mary M. Eckert   +43 more
wiley   +1 more source

Mitochondria‐Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential

open access: yesAdvanced Healthcare Materials, EarlyView.
Mitochondria‐targeted nanotherapies emerge as a promising strategy for combating aging‐associated neurodegenerative disorders (NDs) by restoring mitochondrial function, reducing oxidative stress, and improving neuronal survival. Recent advances in nanotechnology, therapeutic delivery, and translational research are highlighted, providing insights into ...
Dnyandev G. Gadhave   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy